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a  b  s  t  r  a  c  t
The  lipopolysaccharide  (LPS)  is involved  in the  interaction  between  Gram-negative  pathogenic  bacteria
and  host.  Mannose-binding  lectin  (MBL),  complement-activating  soluble  pattern-recognition  receptor
targets  microbial  glycoconjugates,  including  LPS. We studied  its interactions  with  a  set of Yersinia  ente-
rocolitica  O:3  LPS  mutants.  The  wild-type  strain  LPS  consists  of  lipid A  (LA)  substituted  with  an  inner  core
oligosaccharide  (IC)  which  in turn is substituted  either  with  the  O-specific  polysaccharide  (OPS)  or  the
outer  core  hexasaccharide  (OC),  and  sometimes  also  with the  enterobacterial  common  antigen  (ECA).  The
LPS  mutants  produced  truncated  LPS,  missing  OPS,  OC  or  both,  or, in addition,  different  IC constituents
or  ECA.  MBL  bound  to LA-IC,  LA-IC-OPS  and  LA-IC-ECA  but not  LA-IC-OC  structures.  Moreover,  LA-IC  sub-
stitution  with  both  OPS  and  ECA  prevented  the  lectin  binding.  Sequential  truncation  of  the  IC heptoses
demonstrated  that  the  MBL  targets  the  IC  heptose  region.  Furthermore,  microbial  growth  temperature
influenced  MBL  binding;  binding  was  stronger  to bacteria  grown  at room  temperature  (22 ◦C)  than  to  bac-
teria  grown  at 37 ◦C. In conclusion,  our results  demonstrate  that  MBL  can  interact  with  Y.  enterocolitica
LPS,  however,  the  in  vivo  significance  of that  interaction  remains  to  be elucidated.
© 2015  Elsevier  GmbH.  All  rights  reserved.ntroduction
Lipopolysaccharide (LPS), the major surface antigen of Gram-
egative bacteria also known as endotoxin, contains three main
tructural components: the outer membrane integrated lipid A
LA), the core oligosaccharide and, most distal, the O-specific
olysaccharide (OPS), the latter consisting of different numbers
f repeating units (Raetz and Whitfield, 2002; Alexander and
Abbreviations: ECA, enterobacterial common antigen; IC, inner core oligosac-
haride; LA, lipid A; LP, lectin pathway (of complement activation); LPS,
ipopolysaccharide; MASP, mannose-binding lectin-associated serine protease;
BL, mannose-binding lectin; OC, outer core oligosaccharide; OPS, O-specific
olysaccharide; PAMP, pathogen-associated molecular pattern; RT, room tempera-
ure (22 ◦C).
∗ Corresponding author. Tel.: +48 42 2723607; fax: +48 42 2723600.
E-mail address: mcedzynski@cbm.pan.pl (M.  Cedzynski).
ttp://dx.doi.org/10.1016/j.ijmm.2015.07.001
438-4221/© 2015 Elsevier GmbH. All rights reserved.Rietschel, 2001). The core oligosaccharide is generally divided
into the LA-linked heptose-containing inner core (IC), and hexose-
containing outer core (OC) to which the OPS is linked (Fig. 1A).
Rough (R), in contrast to smooth (S), strains lack OPS from their LPS
(Ra chemotype). Deep–rough strains (Rb–Re chemotypes) in turn
have successive truncations of the core oligosaccharide (Raetz and
Whitfield, 2002; Alexander and Rietschel, 2001) as illustrated in
Fig. 1B.
Yersinia enterocolitica is a Gram-negative rod being an etiological
agent of food- or water-transmitted diseases such as enteritis, ente-
rocolitis, mesenteric lymphadenitis and terminal ileitis (Bottone,
1999). It may  also be involved in development of post-infectious
sequelae such as reactive arthritis, myocarditis, glomerulonephri-
tis and erythema nodosum (Bottone, 1999; Huovinen et al., 2010).
Y. enterocolitica is able to grow at a wide range of temperatures
(0–42 ◦C) (Bottone, 1999). The ability of Y. enterocolitica to mul-
tiply at low temperatures as well as in an iron-rich environment
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B
Fig. 1. Schematic structure of LPS. Panel A: LPS typical for majority of Enterobacteriaceae. The empty hexagons reflect the sugar residue variability in the OC and OPS
structures of different strains. The zigzag lines in LA represent fatty acids. Panel B: Schematic structures of the LPS of the Y. enterocolitica serotype O:3 strains used in
this  work. The chemotypes of the O:3 LPS molecules are indicated by grey letters and the grey dashed lines indicate the point(s) of truncations: S, LA-IC-OPS; Ra, LA-
IC-OC;  Rc, LA-IC; Rd1, Rd2 and Re, LA plus truncated IC. The wild type O:3 bacteria produce a mixture of S- and Ra-type LPS molecules. The sugar residues: 6dL-Alt,


























cetyl-d-galactosamine (2-acetamido-2-deoxy-d-galactopyranose); d-Glc, d-glucop
anNAcA, N-acetyl-d-mannosaminouronic acid (2-acetamido-2-deoxy-d-manno-py
-manno-heptopyranose; d-Sug, 2-acetamido-2,6-dideoxy-d-xylo-4-ulopyranose.
nhances the risk of life-threatening infections via transfusion of
ontaminated blood or its products and may  result in septic shock
ith overall fatality rate of 54% (Guinet et al., 2011). Moreover, the
acterium withstands freezing very well and may  survive for pro-
onged periods in frozen food (Norberg, 1981). The chromosome-
nd plasmid-located genes of Y. enterocolitica encode for numer-
us virulence factors enabling the pathogen to invade the host and
o evade the immune response. The biosynthesis of various vir-
lence factors is regulated by the bacterial growth temperature.
or example, the OPS and Yst enterotoxin are optimally synthe-
ized at room temperature (RT), whereas the virulence factors YadA
Yersinia adhesion protein), Ail (attachment-invasion protein) or
ops (Yersinia outer proteins) are expressed only at 37 ◦C (Bottone,
999; Konkel and Tilly, 2000). The level of OPS synthesis at 37 ◦C
as reported to be seven-fold lower in comparison to RT reflect-
ng the repression of the two promoters controlling the OPS gene
luster at 37 ◦C (Bengoechea et al., 2002, 2004). Moreover, bacte-
ial growth phase, low pH, iron concentration, oxygen tension and
onic strength modulate OPS expression (reviewed by Skurnik and
engoechea, 2003).
Y. enterocolitica O:3 (YeO3) is the most frequently iso-
ated causative agent of yersiniosis in Europe (Huovinen et al.,
010; Rastawicki et al., 2009). In contrast to the majority ofse; d-GlcNAc, N-acetyl-d-glucosamine (2-acetamido-2-deoxy-d-glucopyranose); d-
uronic acid); Kdo, 3-deoxy-d-manno-oct-2-ulopyranosonic acid; l,d-Hep, l-glycero-
Enterobacteriaceae,  (where OPS is linked to the OC, Fig. 1A), the IC
of YeO3 LPS was found to be anchoring point either for the OC hex-
asaccharide or the homopolymeric OPS and/or ECA (Skurnik et al.,
1995; Radziejewska-Lebrecht et al., 1998; Pinta et al., 2009, 2012)
thereby the wild type bacteria express at the same time S and Ra
chemotype LPS molecules (Fig. 1B). As shown in Fig. 1B, the IC of
YeO3 is an octasaccharide of two octose, four heptose and two hex-
ose residues (Radziejewska-Lebrecht et al., 1998) while the OC is
a hexasaccharide (Pinta et al., 2009). The OPS is a homopolymer of
-(1 → 2)-linked 6-deoxy-l-altropyranose (Hoffman et al., 1980;
Gorshkova et al., 1985; Bruneteau and Minka, 2003). The OC,  and
likely also the OPS, is linked to the second heptose (Hep II) residue of
IC (Pinta et al., 2012). Both the OPS and OC substitutions are essen-
tial for bacterial virulence (Al-Hendy et al., 1992; Skurnik et al.,
1999). The exact linkage of ECALPS to the LA-IC (Fig. 1B) is not deter-
mined yet although it was indirectly shown to be the Kdo region
(Noszczynska et al., 2015).
The LPS core region is a target of numerous serum proteins,
including the mannose-binding lectin (MBL). MBL  was originally
described as the murine Ra-reactive factor (RaRF), activating the
complement cascade by interaction with Salmonella LPS of Ra
type but not with the smooth or Re chemotypes (Ihara et al.,
1982). Later, MBL  has been demonstrated to react with OPS  or
546 K. Kasperkiewicz et al. / International Journal of Medical Microbiology 305 (2015) 544–552
Table 1
Description of bacterial strains used in this work.
Strain Description LPS chemotypea References
Klebsiella pneumoniae
KO3 Serotype O:3, OPS is a homopolymer of
mannose
S (LA-IC-OC-OPS) Curvall et al. (1973)
Yersinia enterocolitica
6471/76 (YeO3) Serotype O:3, patient stool isolate, wild
type strain.
S (LA-IC-OPS) and Ra
(LA-IC-OC)
Skurnik (1984)
6471/76-c (YeO3-c) Virulence plasmid cured derivative of
6471/76
S (LA-IC-OPS) and Ra
(LA-IC-OC)
Skurnik (1984)
Ye75S Serotype O:3, wild type strain. S (LA-IC-OPS) and Ra
(LA-IC-OC)
Acker et al. (1981)
YeO3-028 Derivative of 6471/76, yadA::Km-GenBlock,
KmR
S  (LA-IC-OPS) and Ra
(LA-IC-OC)
Biedzka-Sarek et al. (2005)
8081-c pYV-cured derivative of wild type serotype O:8
strain 8081
S (LA-IC-OPS) Portnoy et al. (1981)
Ye75R Spontaneous rough mutant of Ye75S Rc (LA-IC) Radziejewska-Lebrecht et al.
(1994)
YeO3-c-R1 Spontaneous rough derivative of strain
6471/76-c
Ra (LA-IC-OC) Al-Hendy et al. (1992)
YeO3-c-Rfb-R7 YeO3-c, Tn5-phoA insertion mutant in OC gene
cluster, pYV− , KmR
Rc (LA-IC) Skurnik et al. (1995, 1999),
Radziejewska-Lebrecht et al.
(1998)
YeO3-c-trs8-R YeO3-c (wzx–wbcKL),  spontaneous rough
mutant, pYV− , KmR
Rc (LA-IC) Skurnik et al. (1995, 1999),
Muszynski et al. (2013)
YeO3-c-trs22-R YeO3-c (wbcKL), spontaneous rough mutant,
pYV−
Rc + (LA-IC-4/6OC)b Skurnik et al. (1995, 1999),
Muszynski et al. (2013)
YeO3-c-trs24-R YeO3-c wbcP, spontaneous rough mutant,
pYV−
Rc (LA-IC) Skurnik et al. (1995, 1999),
Muszynski et al. (2013)
YeO3-c-Ail-R YeO3-c ail,  spontaneous rough mutant,
pYV− , KmR
Ra (LA-IC-OC) Biedzka-Sarek et al. (2005)
YeO3-c-OC YeO3-c (wzx–wbcQ). The whole OC gene
cluster deleted
S (LA-IC-OPS) and Rc
(LA-IC)
Biedzka-Sarek et al. (2005)
YeO3-c-OCR YeO3-c (wzx–wbcQ). Spontaneous rough
mutant
Rc (LA-IC) Biedzka-Sarek et al. (2005)
YeO3-c-ECA YeO3-c (wzzE-wzyE). ECA gene cluster
deleted. Construction as described by Acker
et  al. (1991)
S (LA-IC-OPS) and Ra
(LA-IC-OC)
This work
YeO3-c-R-ECA YeO3-c-R1 (wzzE–wzyE). ECA gene cluster
deleted. Construction as described by Acker
et  al. (1991), pYV, KmR
Ra (LA-IC-OC) This work
YeO3-c-OCR-ECA YeO3-c-OCR (wzzE–wzyE).  ECA gene cluster
deleted. pYV− , KmR
Rc (LA-IC) Rabsztyn et al. (2011)
YeO3-c-OC-ECA YeO3-c-OC (wzzE–wzyE). ECA gene cluster
deleted. Construction as described by Acker
et  al. (1991), pYV− , KmR
S (LA-IC-OPS) and Rc
(LA-IC)
This work
YeO3-c-R1-M205 YeO3-c-R1 hldE::cat-Mu, clmR Re (LA-2/8IC)c Noszczynska et al. (2015)
YeO3-c-R1-M196 YeO3-c-R1 galU::cat-Mu, clmR Rd1 (LA-4/8IC)c Noszczynska et al. (2015)
YeO3-c-R1-M181 YeO3-c-R1 galU::cat-Mu, clmR Rd1 (LA-4/8IC)c Noszczynska et al. (2015)





















a All the Y. enterocolitica strains are ECA-positive, except the ones from which the
b The OC hexasaccharide is truncated by two  glucose residues.
c The IC structures of Rd1, Rd2 and Re chemotype LPSs are shown in Fig. 1B. The I
ore oligosaccharides of some other bacteria (Jiang et al., 1995;
wierzko et al., 2003; Dumestre-Perard et al., 2007). MBL  belongs to
he collectin family: a group of Ca2+-dependent lectins possessing
 collagen-like helical domain. As a pattern-recognition molecule
t recognizes pathogen-associated molecular patterns (PAMPs) of
ariety of microorganisms. It protects the host from infection by
ysis of microbial cells involving complement activation via the
ectin pathway (LP), in which MBL-associated serine proteases
MASPs) take part. Anaphylatoxins released during this process
elp to limit the infection through their chemotactic activities.
n parallel, MBL  may  enhance phagocytosis by direct opsoniza-
ion involving MBL  receptors on phagocytic cells (reviewed by
edzynski et al., 2012).
The aim of this study was to investigate the interaction of MBL
nd Y. enterocolitica and to identify the Yersinia LPS region targeted
y MBL. To this end, wild type strains as well as a set of LPS mutants
xpressing sequentially truncated LPS molecules were used. Addi-
ionally, the influence of growth temperature on MBL  binding was
ested.gene cluster has been deleted.
saccharide is truncated by 4, 5 or 6 sugar residues, respectively.
Material and methods
Bacterial strains, growth conditions and LPS isolation
Bacterial strains used in this work are listed in Table 1. Bacteria
were grown aerobically at 22 ◦C (RT) or 37 ◦C, in LB medium, and in
the presence of kanamycin or chloramphenicol, when required. The
LPS from smooth Y. enterocolitica O:3 and O:8 as well as Klebsiella
pneumoniae O:3 strains was isolated by hot phenol/water method,
according to Westphal and Jann (1965), whereas the LPS of the
rough strains was  isolated by the hot phenol/water extraction fol-
lowed by the phenol/chloroform/petroleum ether method (Galanos
et al., 1969).
Flow cytometryBacterial cultures were suspended from the solid medium into
PBS, centrifuged and fixed with 1.5% formaldehyde. After wash-

























































K. Kasperkiewicz et al. / International Journ
aline supplemented with 0.1% gelatine, 0.3 mM CaCl2 and 2 mM
gCl2 (GVB2+) to OD600 = 1. Then 1 g of recombinant human MBL
R&D Systems, USA) was added to a 100 l aliquot of bacteria and
ncubated for 1 h at 37 ◦C. The bound protein was  detected with
he MBL-specific mAb  HYB 131-01 (BioPorto, Denmark) and FITC-
abeled anti-mouse Ig secondary antibodies (DAKO, Denmark), with
he help of Cytomics FC 500 MPL  Beckman-Coulter (USA) flow
ytometer. Bacteria were detected using log-forward and log-side
catter dot plot. Gating region was set to exclude debris and larger
ggregates of bacteria. A total of 10 000 events were acquired. The
BL  binding was considered positive when the fluorescence value
xceeded the threshold value that was set to be 2 times the average
alue of the corresponding negative control (without added MBL).
estern and affinity blotting, and lectin pathway analysis
The formaline-fixed bacterial suspensions were prepared as
escribed above and then incubated for 2 h at 30 ◦C with normal
uman serum, pre-diluted 1:10 in GVB2+ buffer in a total volume of
00 l. The serum used as a source of the lectin was obtained from a
ealthy volunteer with a normal MBL  level (2 g/ml) and wild type
BL2 genotype (HYPA/LYQA). The samples were then washed with
VB2+, and solubilized in SDS-sample buffer by boiling for 10 min,
nd aliquots equaling to 100 l of the original OD600 = 1 suspen-
ion were separated in 12% SDS–PAGE under reducing conditions.
fter transfer to PFDV membrane, the bound MBL  was detected
ith mAb  HYB 131-01 (BioPorto) as primary and HRP-conjugated
nti-mouse Ig antibodies (DAKO) as secondary antibodies, respec-
ively. The bound antibodies were visualized with an ECL substrate
Santa Cruz Biotechnology, USA). For affinity blotting, LPSs were
eparated using SDS–PAGE and transferred to PVDF membrane.
fter incubation with human serum, the bound MBL  was  detected
ith specific antibodies as described above. To detect lectin path-
ay activation on the PVDF membrane (Bartlomiejczyk et al., 2014),
he serum was diluted 1:10 in the high-ionic strength “MBL-binding
uffer” (20 mM Tris, 1 M NaCl, 10 mM CaCl2, pH 7.4, supplemented
ith 0.1% BSA) to prevent classical pathway activation (Petersen
t al., 2001), and, after incubation at 37 ◦C, the deposited C4c was
etected with specific rabbit antibodies and HRP-conjugated goat
nti-rabbit Ig (DAKO).
LISA
Microtitre MaxiSorp U96 plates (NUNC, Denmark) were coated
ith LPS (5 g/well). After overnight incubation at 4 ◦C, plates
ere washed with calcium-supplemented Tris-buffered saline
TBS-Ca2+) containing 0.05% Tween-20 and blocked with 0.1% BSA
n TBS-Ca2+ (2 h, 37 ◦C). Human serum (a source of MBL) was
iluted 1:50 in “MBL-binding buffer” supplemented with 0.1% BSA.
lates were incubated overnight at 4 ◦C. To estimate MBL  bind-
ng, HYB 131-01 (BioPorto) mAb  and HRP-conjugated anti mouse
g (DAKO) were used as primary and secondary antibodies. As
ubstrate for peroxidase, 2,2′-azino-bis(3-ethylbenz-thiazoline-6-
ulphonic)acid (ABTS, Sigma) was employed. OD405 values were
easured with the use of a Benchmark Plus microplate spectropho-
ometer (Bio-Rad, USA).
tatistical analysis
The statistical significance of the differences in the ELISA OD405
alues obtained from the binding of MBL  to wells coated with LPS
rom different bacteria were compared with the Student’s t test.
he “Statistica” version 10 software (StatSoft Poland) was  used for
ata management and calculations.edical Microbiology 305 (2015) 544–552 547
Results
Interaction of MBL with whole bacterial cells
A set of LPS mutant strains derived from the Y. enterocolitica
serotype O:3 strain 6471/76 (YeO3) expressing sequentially trun-
cated LPS molecules were used to map  the LPS region responsible
for the interaction with MBL. The K. pneumoniae O:3 was  used as a
positive control as its OPS is a homopolymer of d-mannopyranose
(d-Manp). When analyzed by flow cytometry neither the wild type
strain YeO3 nor the spontaneous rough mutant YeO3-c-R1 express-
ing Ra/S and Ra chemotype LPS, respectively, were able to bind
MBL, however, MBL  bound efficiently to the Rc chemotype strain
YeO3-c-Rfb-R7 (Fig. 2A and B). This was also the case with other
Rc chemotype strains (Fig. 2C) suggesting that MBL  binds to a
structure in the LA-IC part of Y. enterocolitica LPS. No significant
growth temperature effect was  observed (Fig. 2A). Furthermore, we
could not detect any differences in MBL  binding between parental
and virulence plasmid-cured or ail (attachment-invasion protein)
knock-out strains (data not shown).
The flow cytometry results were confirmed by analyzing MBL
binding to bacteria by Western blotting. The bacteria were incu-
bated in 10% human serum, washed thoroughly and the whole cell
lysates were subjected to Western blotting to detect MBL. In this
experiment, neither YeO3 nor other smooth serotype O:3 or O:8
strains expressing S/Ra chemotype LPS bound MBL  (Fig. 3A). This
was also the case with the Ra chemotype (LA-IC-OC expressing)
YeO3-c-R1 bacteria (Fig. 3B). Interesting results were obtained with
the extensive set of YeO3 derivatives that differ in LPS composi-
tion and expression of ECA (Fig. 3B–D). While strong MBL  binding
could be seen to all four Rc chemotype (LA-IC) strains (Fig. 3B),
significantly decreased binding was  seen to YeO3-c-trs22-R bacte-
ria. This strain, due to deletion of the glucosyltransferase encoding
genes wbcK and wbcL (Skurnik et al., 1999), produces a truncated
OC missing both of the glucose residues and only partially sub-
stitutes the LA-IC molecules with the truncated OC  (Pinta et al.,
2009). Thus the bacteria express a mixture of LA-IC and LA-IC-4/6OC
molecules, and apparently only the LA-IC binds MBL, explaining
the reduced binding. In conclusion, the missing of OC seemed to be
a sine qua non condition for MBL  access to the receptor although
some minor (trace) binding could be observed to the Ra chemo-
type strain YeO3-c-R-ECA (Fig. 3C). Surprisingly, in OC-negative
strains the expression of either OPS or ECA did not abolish MBL
binding, however, binding was blocked when both OPS and ECA
were present simultaneously as in the case of YeO3-c-OC strain
(Figs. 2C and 3C).
Finally, the results presented in Fig. 3D suggested that the IC
heptoses are the MBL  targets. Truncation of the IC from the wild
type four heptoses to two  (Fig. 1B), as is the case in the galU mutant
strains YeO3-c-R1-M196 and YeO3-c-R1-M181, did not abolish
MBL  binding to bacteria (Fig. 3D), however, a further truncation to
one heptose in the waaF mutant strain YeO3-c-R1-M164 or down
to lipid A substituted by the Kdo residues only, as in the hldE mutant
strainYeO3-c-R1-M205, completely abolished the binding ability of
MBL  to whole bacteria.
Interaction of MBL with isolated LPS
To confirm the above whole bacterial cell binding data indicat-
ing that MBL  binds to the IC heptoses we used ELISA to study the
MBL  binding to LPS isolated from a set of Yersinia strains cultivated
at 22 ◦C and 37 ◦C. Interestingly, in contrast to whole cells, a clear
growth temperature dependence could be seen especially with the
Rc chemotype LPS such that the LPS isolated from 22 ◦C grown bac-
teria bound significantly more MBL  than the 37 ◦C one (Fig. 4A). The
effect was not so pronounced with Rd1 and Rd2 chemotype LPSs.
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Fig. 2. Analysis of MBL  binding to Y. enterocolitica by flow cytometry. Bacteria were washed with PBS and fixed with formaldehyde. After washing the bacteria were incubated
with  recombinant human MBL  and the bound MBL  was detected with mAb HYB 131-01 and FITC-labeled anti-mouse Ig secondary antibodies. K. pneumoniae O:3 (KO3) cells
were  used as positive control. The results are given as means ± standard deviation. The number of repeats for each strain is indicated in parentheses under the strain
designation. The LPS chemotypes of the strains are indicated above the columns. Note that some strains express two different LPS chemotypes at the same time. S, LA-IC-OPS;
Ra,  LA-IC-OC; Rc, LA-IC. Gating region was set to exclude debris and larger aggregates of bacteria. A total of 10 000 events were acquired. The MBL  binding was  considered
positive when the fluorescence value exceeded the threshold value that was  set to be 2 times the average value of the corresponding negative control (without added MBL).
Panel  A: Binding of recombinant MBL  to Y. enterocolitica Rc, Ra and Ra/S chemotype strains cultivated at 22 ◦C and 37 ◦C. Panel B: Flow cytometry curves for two strains
i presen









n  panel A. Representative data from one of 2 or 3 independent experiments are 
CA-positive and -negative strains cultivated at 22 ◦C (black bars). The ECA extensi
ontrols  (no MBL  added).
hile MBL  did not bind to the Rd2 chemotype bacteria (YeO3-c-R1-
164) it bound to LPS isolated from them, suggesting that under
he conditions used in the ELISA assay a single heptose residue was
ufficient for MBL  binding. The number of heptoses made a differ-
nce as strongest MBL  binding took place with the four-heptose Rc
hemotype LPS. On the other hand, the Re-, Ra-, and Ra/S chemo-
ype LPSs showed no MBL  binding. This was also the case withted. Panel C: Binding of MBL  to Y. enterocolitica Rc, Ra, Rc/S and Ra/S chemotype
the strain name indicates ECA-negative mutants. The white bars indicate negative
YeO3-c-trs22-R LPS, carrying the truncated OC, that in contrast to
the weak MBL  binding in the Western blotting, showed no MBL
binding in the ELISA assay (compare Figs. 3B and 4A). Unexpectedly,
the binding of MBL  to LPS from the Rc chemotype ECA-negative
strain YeO3-c-OC-R-ECA was significantly lower than binding to
the LPSs of the two Rc chemotype ECA-positive strains, YeO3-c-
Rfb-R7 and YeO3-c-trs24-R (Fig. 4B). This could indicate that ECA
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Fig. 3. Analysis of MBL  binding to Y. enterocolitica bacteria by Western blotting. The bacteria were incubated in 10% human serum, washed thoroughly and equal amounts
of  the whole cell lysates were subjected to gel-electrophoresis and Western blotting to detect bound MBL. K. pneumoniae O:3 (KO3) cells were used as positive control. The
negative controls incubated without serum were completely negative (not shown). The LPS and ECA constituents of the tested strains are indicated above the lanes and the
strains and growth temperature below the blots. The bound MBL  was detected with mAb  HYB 131-01 (BioPorto). Panel A, Y. enterocolitica serotype O:3 and O:8  strains with














ith  a single repeat unit in addition to the LA-IC-OPS (chemotype S) LPS. Panel B, 
trains missing OPS and/or OC and/or ECA. The ECA extension in the strain name ind
/8,  3/8, 2/8 indicate number of sugar residues in the IC.
unctions as an additional MBL  target in the absence of both OC and
PS.
BL  affinity blottingThe MBL  binding to purified LPS was further analyzed by affin-
ty blotting. The LPS samples were run in SDS–PAGE and blotted to
ransfer membrane that was subsequently incubated with human
ig. 4. Analysis of MBL  binding to different chemotype LPSs isolated from the Y. enterocoli
oated  with LPS and then incubated with 1:50 diluted human serum. Bound MBL  was det
PS  of various chemotypes. Panel B: Lack of ECA reduces MBL  binding to Rc chemotype LPS
he  strain name indicates the ECA-negative mutant. The statistical significance of the diffe
ith  LPS from different bacteria were compared with the Student’s t test. Data are presenrocolitica O:3 ECA-positive Ra-Rc chemotype strains. Panel C, Y. enterocolitica O:3
s ECA-negative mutants. Panel D, Y. enterocolitica O:3 deep-rough mutants (Rd-Re).
serum. The bound MBL  was  detected using the MBL-specific mAb
(Fig. 5A). In the affinity blotting, in contrast to whole bacteria
results, MBL  bound to Ra/S and Ra chemotype LPSs but only to
the low molecular mass fractions (Fig. 5A). This probably reflects
the fact that bacteria produce a heterogenous population of LPS
molecules including those with incomplete substitution of the
inner core with OC or OPS. No MBL  binding took place with Re
chemotype LPS.
tica O:3 LPS mutant strains cultivated at 22 ◦C and 37 ◦C. Microtiter plate wells were
ected with MBL-specific mAb HYB 131-01. Panel A: MBL binding to Y. enterocolitica
 (data for LPS from bacteria cultivated at 22 ◦C are presented). The ECA extension in
rences in the ELISA OD405 values obtained from the binding of MBL  to wells coated
ted as mean ± SD from at least three independent experiments.
550 K. Kasperkiewicz et al. / International Journal of M
Fig. 5. Interaction of MBL  with purified LPS from different Y. enterocolitica O:3
LPS  mutants. The strains and growth temperature are indicated below and the
LPS chemotypes above the images. The locations of LA-IC, LA-IC-OC and LA-IC-OPS
in  the gel are indicated at the left. After SDS–PAGE the LPSs were transferred to
PFDV membranes. Panel A: Affinity blotting to detect binding of human serum MBL





























ound MBL was  detected by mAb  HYB 131-01 (anti-MBL). Panel B: Activation of the
omplement lectin pathway demonstrated as deposition of C4c under conditions
reventing classical pathway activity.
ectin pathway activation
To study whether the MBL  interaction with Y. enterocolitica LPS
ould activate the complement lectin pathway, the deposition of
4c was analyzed. Indeed, the interaction of serum MBL  with the
PSs resulted in the activation of the complement lectin pathway
Fig. 5B). As expected, due to lack of MBL  binding to the Re chemo-
ype LPS, no C4c deposition took place to it. Here, however, we have
o take into account the possibility that complement activation
ould occur upon recognition of LPS by other pattern-recognizing
olecules, e.g.,  ficolins. This, on the other hand, is not very likely as
e could observe only a very weak reactivity of ficolin-2 (L-ficolin)
ut not of ficolin-1 (M-ficolin) or ficolin-3 (H-ficolin) (tested at 1:10
erum dilution) with Ra/S, Ra and Re chemotype LPSs (data not
hown).
iscussion
In this work we provide evidence that human serum MBL  inter-
cts with Y. enterocolitica and, specifically, the target structure for
BL  is the IC heptose region of the LPS. The minimal structure
equired for the recognition in LPS exposed on bacterial surface
as the Hepp–Hepp disaccharide but the most efficient binding
as observed when all four Hepp residues were present (Fig. 3,
anels C and D). On the other hand, a single heptose residue was
ufficient for MBL  binding when isolated LPS was used (Figs. 4A and
).Based on our findings, it seems that the Hepp residues are
ess accessible for the MBL  in LPS incorporated into the cell enve-
ope than in purified LPS. The difference in the amount of purified
PS coated on immunoplate well (ELISA) and present on bacterialedical Microbiology 305 (2015) 544–552
surface (Western blot, flow cytometry) may  affect the observed
reactivity as well. Furthermore, in Y. enterocolitica the MBL binding
was shown to be affected by the three LA-IC substitutions, namely
OPS, OC and ECA. The OC substitution had the strongest block-
ing effect. Only marginal MBL  binding to OC-positive LPS was seen
for bacteria missing both ECA and/or OPS (see strains YeO3-c-ECA
and YeO3-c-R-ECA, Figs. 2C and 3C), however, in OC-ECA-positive
strain the lack of OPS did not influence the blocking (see strain
YeO3-c-R1, Figs. 2A and 3B). On the other hand, single OPS or ECA-
substitution of LA-IC was  not able to block MBL  binding (see strains
YeO3-c-OCR and YeO3-c-OC-ECA, Fig. 3C), however, simultaneous
presence of both OPS and ECA did (see strain YeO3-c-OC, Figs. 2C
and 3C).
Although the most effective LPS ligands of MBL  are mannose-
containing OPS as in the case of K. pneumoniae O:3, Escherichia
coli O:8 and O:9, interaction of MBL  with the core oligosaccharide
may  lead to serious biological consequences (early-phase endo-
toxic shock, death) as was  demonstrated by Swierzko et al. (2003) in
a murine model. A Ra chemotype LPS-reactive factor was  identified
and later recognized as MBL  that interacted with Ra-chemotype
Salmonella LPS resulting in complement activation (Ihara et al.,
1982, 1991; Ji et al., 1988, 1993; Matsushita et al., 1992). The MBL
target sugar residues were identified within both the OC and IC
regions of LPS, including 2-acetamido-2-deoxy-d-glucopyranose
(d-GlcpNAc) in Proteus vulgaris O25 LPS (Swierzko et al., 2003),
and d-GlcpNAc and l,d-Hepp in Escherichia coli (Kawasaki et al.,
1989), respectively. Similarly, the OC d-GlcNAc or the IC hep-
toses were demonstrated to be responsible for the interaction
of Salmonella enterica serovar Typhimurium rough mutants with
MBL  (Devyatyarova-Johnson et al., 2000). In contrast to our find-
ings, Dumestre-Perard et al. (2007) demonstrated for Salmonella
Minnesota that MBL  recognizes S, Ra, Rc and Rd chemotype
LPS.
The more efficient binding of MBL  to LPS of the ECA-positive but
OC- and OPS-negative strain YeO3-c-OCR when compared to LPS
of the YeO3-c-OCR–ECA strain might suggest that ECA could be an
additional MBL  target. On the other hand, MBL  did not bind to ECA-
positive LA-IC-OC bacteria (Fig. 3B), or to isolated ECAPG where ECA
is linked to phosphatidylglycerol, in contrast to the ECALPS, where
ECA is attached to IC of LPS (data not shown) suggesting that ECA
rather may  modify MBL  binding to the IC than to be specifically
recognized.
The core-lipid A region of LPS plays an important role in the
interaction between pathogenic bacteria and the membrane and
serum proteins of the human or animal hosts and thereby influ-
ences the rate of bacterial elimination (Weiss, 2003). However, the
LPS core region is often masked by long-chained OPS. Interest-
ingly, Wuorela et al. (1993) showed that monocytes may  modify
LPS of ingested Yersinia and present it on the monocyte surface,
mainly as a rough form. The structure and composition of LPS
in Yersinia both at the LA-IC and the OPS level is variable and
depends on the growth conditions of the bacteria with tempera-
ture playing a prominent role. For example, in Yersinia pestis the
acylation status of LA is temperature-dependent; tetra-acylated at
37 ◦C and penta- and hexa-acylated at 25 ◦C (Knirel et al., 2005a,b).
Moreover, at lower temperature the content of 4-amino-4-deoxy-
l-arabinopyranose (Arap4N) was  increased (Knirel et al., 2005a,b).
Similar findings were also made with Y. enterocolitca (Reines et al.,
2012). The enteropathogenic Yersinia have also a tendency to down-
regulate OPS expression in vitro at 37 ◦C suggesting that under
such conditions the IC heptoses might be exposed to MBL  bind-
ing.In this work we  noticed more efficient MBL  binding to LPS
isolated from bacteria grown at 22 ◦C reflecting perhaps slight
temperature-dependent differences in IC exposure. It is worth not-
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o play any role in interaction of MBL  with Yersinia cells. In con-
lusion, our results demonstrate that MBL  interacts with a variety
f Y. enterocolitica LPS molecules lacking OC oligosaccharide. These
ight include both S type LPS (possessing OPS, OC-negative) and
PS molecules processed by immune cells, however the in vivo sig-
ificance of MBL  reactivity reported here remains to be elucidated.
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